Business opportunities for Ghana and the EU

Under the EU Global Gateway strategy,  pharmaceuticals and vaccines are priority sectors for EU investments. The pharmaceutical industry is one of Ghana’s strategic anchor industries and can be a potent driver for economic transformation. At the GHEUBF last year, the EU launched the Ghana Component of the  ‘Special Measure’ Team Europe initiative on manufacturing and access to vaccines, medicines and health technologies in Africa (MAV+). On Ghana’s side, a new policy for the pharmaceutical sector has been under development, a vital component of which could be an incentive regime. With Ghana’s increased ambitions but also capabilities (cf. recent FDA upgrade, now being able to test vaccines) to produce high-quality medicines and embarking on vaccine production, there are currently many opportunities for EU business to engage and invest in this sector in. This will not only increase access to essential drugs and vaccines, but also create more decent jobs and generate greater domestic revenues.